Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 5
2005 8
2006 5
2007 4
2008 2
2009 5
2010 3
2011 3
2012 2
2013 10
2014 6
2015 7
2016 9
2017 10
2018 8
2019 9
2020 9
2021 3
2022 6
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use.
Papp Z, Agostoni P, Alvarez J, Bettex D, Bouchez S, Brito D, Černý V, Comin-Colet J, Crespo-Leiro MG, Delgado JF, Édes I, Eremenko AA, Farmakis D, Fedele F, Fonseca C, Fruhwald S, Girardis M, Guarracino F, Harjola VP, Heringlake M, Herpain A, Heunks LMA, Husebye T, Ivancan V, Karason K, Kaul S, Kivikko M, Kubica J, Masip J, Matskeplishvili S, Mebazaa A, Nieminen MS, Oliva F, Papp JG, Parissis J, Parkhomenko A, Põder P, Pölzl G, Reinecke A, Ricksten SE, Riha H, Rudiger A, Sarapohja T, Schwinger RHG, Toller W, Tritapepe L, Tschöpe C, Wikström G, Lewinski DV, Vrtovec B, Pollesello P. Papp Z, et al. Among authors: vrtovec b. J Cardiovasc Pharmacol. 2020 Jul;76(1):4-22. doi: 10.1097/FJC.0000000000000859. J Cardiovasc Pharmacol. 2020. PMID: 32639325 Free PMC article. Review.
Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction.
Butt JH, Dewan P, Jhund PS, Anand IS, Atar D, Ge J, Desai AS, Echeverria LE, Køber L, Lam CSP, Maggioni AP, Martinez F, Packer M, Rouleau JL, Sim D, Van Veldhuisen DJ, Vrtovec B, Zannad F, Zile MR, Gong J, Lefkowitz MP, Rizkala AR, Solomon SD, McMurray JJV. Butt JH, et al. Among authors: vrtovec b. J Am Coll Cardiol. 2022 Sep 20;80(12):1130-1143. doi: 10.1016/j.jacc.2022.06.037. Epub 2022 Aug 29. J Am Coll Cardiol. 2022. PMID: 36050227 Free article. Clinical Trial.
Cell Therapy in Heart Failure with Preserved Ejection Fraction.
Frljak S, Poglajen G, Vrtovec B. Frljak S, et al. Among authors: vrtovec b. Card Fail Rev. 2022 Mar 21;8:e08. doi: 10.15420/cfr.2021.21. eCollection 2022 Jan. Card Fail Rev. 2022. PMID: 35399548 Free PMC article. Review.
Stem Cell and Left Ventricular Assist Device Combination Therapy.
Poglajen G, Gregoric ID, Radovancevic R, Vrtovec B. Poglajen G, et al. Among authors: vrtovec b. Circ Heart Fail. 2019 Feb;12(2):e005454. doi: 10.1161/CIRCHEARTFAILURE.118.005454. Circ Heart Fail. 2019. PMID: 30759999 Review.
Stem Cell Therapy for Chronic and Advanced Heart Failure.
Poglajen G, Frljak S, Zemljič G, Cerar A, Okrajšek R, Šebeštjen M, Vrtovec B. Poglajen G, et al. Among authors: vrtovec b. Curr Heart Fail Rep. 2020 Oct;17(5):261-270. doi: 10.1007/s11897-020-00477-9. Curr Heart Fail Rep. 2020. PMID: 32783146 Review.
Renal effects of levosimendan: a consensus report.
Yilmaz MB, Grossini E, Silva Cardoso JC, Édes I, Fedele F, Pollesello P, Kivikko M, Harjola VP, Hasslacher J, Mebazaa A, Morelli A, le Noble J, Oldner A, Oulego Erroz I, Parissis JT, Parkhomenko A, Poelzl G, Rehberg S, Ricksten SE, Rodríguez Fernández LM, Salmenperä M, Singer M, Treskatsch S, Vrtovec B, Wikström G. Yilmaz MB, et al. Among authors: vrtovec b. Cardiovasc Drugs Ther. 2013 Dec;27(6):581-90. doi: 10.1007/s10557-013-6485-6. Cardiovasc Drugs Ther. 2013. PMID: 23929366 Free PMC article. Review.
Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period: The multinational randomized LeoDOR trial.
Pölzl G, Altenberger J, Comín-Colet J, Delgado JF, Fedele F, García-González MJ, Gustafsson F, Masip J, Papp Z, Störk S, Ulmer H, Maier S, Vrtovec B, Wikström G, Zima E, Bauer A; LeoDOR Investigators. Pölzl G, et al. Among authors: vrtovec b. Eur J Heart Fail. 2023 Nov;25(11):2007-2017. doi: 10.1002/ejhf.3006. Epub 2023 Sep 4. Eur J Heart Fail. 2023. PMID: 37634941 Clinical Trial.
Effect of allogeneic adipose tissue-derived mesenchymal stromal cell treatment in chronic ischaemic heart failure with reduced ejection fraction - the SCIENCE trial.
Qayyum AA, van Klarenbosch B, Frljak S, Cerar A, Poglajen G, Traxler-Weidenauer D, Nadrowski P, Paitazoglou C, Vrtovec B, Bergmann MW, Chamuleau SAJ, Wojakowski W, Gyöngyösi M, Kraaijeveld A, Hansen KS, Vrangbaek K, Jørgensen E, Helqvist S, Joshi FR, Johansen EM, Follin B, Juhl M, Højgaard LD, Mathiasen AB, Ekblond A, Haack-Sørensen M, Kastrup J; SCIENCE Investigators. Qayyum AA, et al. Among authors: vrtovec b. Eur J Heart Fail. 2023 Apr;25(4):576-587. doi: 10.1002/ejhf.2772. Epub 2023 Jan 31. Eur J Heart Fail. 2023. PMID: 36644821 Free article. Clinical Trial.
105 results